Thorac Cardiovasc Surg 2022; 70(06): 475-481
DOI: 10.1055/s-0042-1743594
Original Cardiovascular

Tricuspid Valve Surgery in Patients Receiving Left Ventricular Assist Devices

Hongtao Tie*
1   Department of Cardiothoracic Surgery, University Hospital Muenster, Muenster, Germany
2   Department of Cardiothoracic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
,
Rui Shi*
3   Service de médecine intensive-réanimation, Université Paris-Saclay, AP-HP, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France
,
Henryk Welp
1   Department of Cardiothoracic Surgery, University Hospital Muenster, Muenster, Germany
,
Sven Martens
1   Department of Cardiothoracic Surgery, University Hospital Muenster, Muenster, Germany
,
Zhenhan Li
4   Department of Anaesthesiology, Intensive Care Medicine and Pain Medicine, University Hospital Muenster, Muenster, Germany
,
Jürgen R. Sindermann
1   Department of Cardiothoracic Surgery, University Hospital Muenster, Muenster, Germany
,
Sabrina Martens
1   Department of Cardiothoracic Surgery, University Hospital Muenster, Muenster, Germany
› Author Affiliations
Funding None.

Abstract

Background Tricuspid regurgitation (TR) is common and related to poor prognosis in patients after left ventricular assist device (LVAD) implantation. The concomitant tricuspid valve surgery (TVS) at the time of LVAD implantation on short and long-term outcomes are controversial in current evidence.

Methods This is a single-center, observational, retrospective study. We enrolled patients with moderate-to-severe TR who received LVAD implantations from 2009 to 2020. Postoperative right ventricular failure (RVF), right ventricular assist device (RVAD) use, hospital mortality, new-onset renal replacement therapy (RRT), and acute kidney injury (AKI) were evaluated retrospectively.

Results Sixty-eight patients were included, 36 with and 32 without concomitant TVS. Baseline characteristics did not differ between the two groups. Patients receiving TVS had significantly increased incidences of postoperative RVF (52.8 vs. 25.0%, p = 0.019), RVAD implantation (41.7 vs. 18.8%, p = 0.041), and new-onset RRT (22.2 vs. 0%, p = 0.004). No difference in the incidence of AKI and hospital mortality was detected. Besides, these associations remained consistent in patients who underwent LVAD implantation via median sternotomy. During a median follow-up of 2.76 years, Kaplan–Meier analysis and competing-risk analysis showed that TVS was not associated with better overall survival in patients after LVAD implantation compared with the no-TVS group.

Conclusion Our study suggests that concomitant TVS failed to show benefits in patients receiving LVAD implantation. Even worse, concomitant TVS is associated with significantly increased incidences of RVF, RVAD use, and new-onset of RRT. Considering the small sample size and short follow-up, these findings warrant further study.

* Both authors contributed equally to this work.


Author Contributions

H.T. and S.M. conceived the study and participated in the design. H.T., H.W., S.M., Z.L., and J.S. collected the data. H.T. and R.S. performed statistical analyses. H.T. and R.S. drafted the manuscript. Z.L. helped to draft the manuscript. S.M. revised the manuscript critically for important intellectual content. All authors read and approved the final manuscript.


Ethical Approval

This study was approved by the ethics committee of the Westfalen-Lippe Medical Association and the Westfälischen Wilhelms-Universität Münster (No. 2021-879-f-S).


Supplementary Material



Publication History

Received: 17 November 2021

Accepted: 24 January 2022

Article published online:
04 July 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Han JJ, Acker MA, Atluri P. Left ventricular assist devices. Circulation 2018; 138 (24) 2841-2851
  • 2 Miller LW, Pagani FD, Russell SD. et al; HeartMate II Clinical Investigators. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007; 357 (09) 885-896
  • 3 Rose EA, Gelijns AC, Moskowitz AJ. et al; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001; 345 (20) 1435-1443
  • 4 Slaughter MS, Rogers JG, Milano CA. et al; HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361 (23) 2241-2251
  • 5 Badano LP, Muraru D, Enriquez-Sarano M. Assessment of functional tricuspid regurgitation. Eur Heart J 2013; 34 (25) 1875-1885
  • 6 Piacentino III V, Williams ML, Depp T. et al. Impact of tricuspid valve regurgitation in patients treated with implantable left ventricular assist devices. Ann Thorac Surg 2011; 91 (05) 1342-1346 , discussion 1346–1347
  • 7 Milano C, Pagani FD, Slaughter MS. et al; ADVANCE Investigators. Clinical outcomes after implantation of a centrifugal flow left ventricular assist device and concurrent cardiac valve procedures. Circulation 2014; 130 (11, Suppl 1): S3-S11
  • 8 Kormos RL, Teuteberg JJ, Pagani FD. et al; HeartMate II Clinical Investigators. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 2010; 139 (05) 1316-1324
  • 9 Nakazato T, Yoshioka D, Toda K. et al. Impact of tricuspid regurgitation on late right ventricular failure in left ventricular assist device patients ∼can prophylactic tricuspid annuloplasty prevent late right ventricular failure?. J Cardiothorac Surg 2021; 16 (01) 99
  • 10 Veen KM, Muslem R, Soliman OI. et al. Left ventricular assist device implantation with and without concomitant tricuspid valve surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg 2018; 54 (04) 644-651
  • 11 Potapov EV, Antonides C, Crespo-Leiro MG. et al. 2019 EACTS Expert Consensus on long-term mechanical circulatory support. Eur J Cardiothorac Surg 2019; 56 (02) 230-270
  • 12 Mullan C, Caraballo C, Ravindra NG. et al. Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantation. J Heart Lung Transplant 2020; 39 (09) 926-933
  • 13 Robertson JO, Grau-Sepulveda MV, Okada S. et al. Concomitant tricuspid valve surgery during implantation of continuous-flow left ventricular assist devices: a Society of Thoracic Surgeons database analysis. J Heart Lung Transplant 2014; 33 (06) 609-617
  • 14 Machado MN, Nakazone MA, Maia LN. Acute kidney injury based on KDIGO (Kidney Disease Improving Global Outcomes) criteria in patients with elevated baseline serum creatinine undergoing cardiac surgery. Rev Bras Cir Cardiovasc 2014; 29 (03) 299-307
  • 15 Riebandt J, Schaefer A, Wiedemann D. et al. Concomitant cardiac surgery procedures during left ventricular assist device implantation: single-centre experience. Ann Cardiothorac Surg 2021; 10 (02) 248-254
  • 16 Veen KM, Caliskan K, de By TMMH. et al. Outcomes after tricuspid valve surgery concomitant with left ventricular assist device implantation in the EUROMACS registry: a propensity score matched analysis. Eur J Cardiothorac Surg 2019; 56 (06) 1081-1089
  • 17 Pagani FD. Right heart failure after left ventricular assist device placement: medical and surgical management considerations. Cardiol Clin 2020; 38 (02) 227-238
  • 18 Cheung AW, White CW, Davis MK, Freed DH. Short-term mechanical circulatory support for recovery from acute right ventricular failure: clinical outcomes. J Heart Lung Transplant 2014; 33 (08) 794-799
  • 19 Morgan JA, John R, Lee BJ, Oz MC, Naka Y. Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality. Ann Thorac Surg 2004; 77 (03) 859-863
  • 20 Lampert BC, Teuteberg JJ. Right ventricular failure after left ventricular assist devices. J Heart Lung Transplant 2015; 34 (09) 1123-1130
  • 21 Potapov EV, Stepanenko A, Dandel M. et al. Tricuspid incompetence and geometry of the right ventricle as predictors of right ventricular function after implantation of a left ventricular assist device. J Heart Lung Transplant 2008; 27 (12) 1275-1281
  • 22 Piacentino III V, Ganapathi AM, Stafford-Smith M. et al. Utility of concomitant tricuspid valve procedures for patients undergoing implantation of a continuous-flow left ventricular device. J Thorac Cardiovasc Surg 2012; 144 (05) 1217-1221
  • 23 Carmona A, Hoang Minh T, Perrier S. et al. Minimally invasive surgery for left ventricular assist device implantation is safe and associated with a decreased risk of right ventricular failure. J Thorac Dis 2020; 12 (04) 1496-1506
  • 24 Moon MR, Bolger AF, DeAnda A. et al. Septal function during left ventricular unloading. Circulation 1997; 95 (05) 1320-1327
  • 25 Maltais S, Topilsky Y, Tchantchaleishvili V. et al. Surgical treatment of tricuspid valve insufficiency promotes early reverse remodeling in patients with axial-flow left ventricular assist devices. J Thorac Cardiovasc Surg 2012; 143 (06) 1370-1376
  • 26 Mulzer J, Krastev H, Hoermandinger C. et al. Development of tricuspid regurgitation and right ventricular performance after implantation of centrifugal left ventricular assist devices. Ann Cardiothorac Surg 2021; 10 (03) 364-374
  • 27 McBride WT, Kurth MJ, McLean G. et al. Stratifying risk of acute kidney injury in pre and post cardiac surgery patients using a novel biomarker-based algorithm and clinical risk score. Sci Rep 2019; 9 (01) 16963
  • 28 Doddakula K, Al-Sarraf N, Gately K. et al. Predictors of acute renal failure requiring renal replacement therapy post cardiac surgery in patients with preoperatively normal renal function. Interact Cardiovasc Thorac Surg 2007; 6 (03) 314-318